908 Devices Share Price (NASDAQ: MASS)

$6.25

▲

-0.01

(-0.16%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive 908 Devices Stock chart to analyse performance

908 Devices stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$6.15
Today's High:$6.27
$6.25
1.6%
Downside
Day's Volatility :1.91%
Upside
0.32%
52 Weeks Low:$1.81
52 Weeks High:$8.06
$6.25
71.04%
Downside
52 Weeks Volatility :77.54%
Upside
22.46%

908 Devices Stock Returns

Period	908 Devices Inc.	Sector (Technology)	Index (Russel 2000)
3 Months	4.96%	13.7%	0.0%
6 Months	215.4%	16.4%	0.0%
1 Year	67.88%	19.1%	0.0%
3 Years	-65.87%	92.2%	-4.7%

908 Devices Inc. Key Stats

Check 908 Devices key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$6.26
Open	$6.27
Today's High	$6.27
Today's Low	$6.15
Market Capitalization	$225.9M
Today's Volume	$231.0K
52 Week High	$8.06
52 Week Low	$1.81
Revenue TTM	$65.6M
EBITDA	$-44.2M
Earnings Per Share (EPS)	$-2.36
Profit Margin	-28.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-53.4%

Stock Returns calculator for 908 Devices Stock including INR - Dollar returns

The 908 Devices stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

908 Devices investment value today

Current value as on today

₹1,73,295

Returns

₹73,295

(+73.29%)

Returns from 908 Devices Stock

₹68,011 (+68.01%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards 908 Devices Stock

67%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for 908 Devices Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in 908 Devices Inc.

Name
Holdings %
Name
Holdings %
Awm Investment Company Inc
14.42%
ARK Investment Management LLC
7.34%
BlackRock Inc
4.85%
Vanguard Group Inc
3.97%
Gm Advisory Group Inc
3.23%
First Light Asset Management, LLC
2.96%

Analyst Recommendation on 908 Devices Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for 908 Devices(by analysts ranked 0 to 5 stars)

908 Devices Share Price Target

What analysts predicted

Upside of 60.0%

Target:

$10.00

Current:

$6.25

908 Devices share price target is $10.00, a slight Upside of 60.0% compared to current price of $6.25 as per analysts' prediction.

908 Devices Stock Insights

Price Movement
In the last 6 months, MASS stock has moved up by 178.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 11.77M → 13.03M (in $), with an average increase of 9.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 43.60M → -13.30M (in $), with an average decrease of 130.5% per quarter
MASS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 231.1%

908 Devices Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$18.0M	↓ 18.51%
Net Income	$-15.2M	↑ 101.75%
Net Profit Margin	-84.6%	↓ 50.43%

	FY20	Y/Y Change
Revenue	$26.9M	↑ 49.64%
Net Income	$-6.9M	↓ 54.38%
Net Profit Margin	-25.79%	↑ 58.81%

	FY21	Y/Y Change
Revenue	$42.2M	↑ 56.93%
Net Income	$-22.1M	↑ 218.86%
Net Profit Margin	-52.4%	↓ 26.61%

	FY22	Y/Y Change
Revenue	$46.9M	↑ 11.01%
Net Income	$-31.7M	↑ 43.53%
Net Profit Margin	-67.75%	↓ 15.35%

	FY23	Y/Y Change
Revenue	$50.2M	↑ 7.21%
Net Income	$-36.4M	↑ 14.66%
Net Profit Margin	-72.47%	↓ 4.72%

	FY24	Y/Y Change
Revenue	$59.6M	↑ 18.72%
Net Income	$-72.2M	↑ 98.37%
Net Profit Margin	-121.09%	↓ 48.62%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$10.0M	↓ 30.38%
Net Income	$-10.9M	↑ 46.95%
Net Profit Margin	-109.27%	↓ 57.5%

	Q2 FY24	Q/Q Change
Revenue	$14.0M	↑ 40.6%
Net Income	$-12.5M	↑ 14.94%
Net Profit Margin	-89.33%	↑ 19.94%

	Q3 FY24	Q/Q Change
Revenue	$16.8M	↑ 19.41%
Net Income	$-29.3M	↑ 133.46%
Net Profit Margin	-174.66%	↓ 85.33%

	Q4 FY24	Q/Q Change
Revenue	$18.8M	↑ 12.2%
Net Income	$-19.4M	↓ 33.62%
Net Profit Margin	-103.33%	↑ 71.33%

	Q1 FY25	Q/Q Change
Revenue	$11.8M	↓ 37.42%
Net Income	$43.6M	↓ 324.23%
Net Profit Margin	370.24%	↑ 473.57%

	Q2 FY25	Q/Q Change
Revenue	$13.0M	↑ 10.68%
Net Income	$-13.3M	↓ 130.52%
Net Profit Margin	-102.08%	↓ 472.32%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$8.1M	↓ 34.29%

	FY20	Y/Y Change
Profit	$14.9M	↑ 83.26%

	FY21	Y/Y Change
Profit	$23.2M	↑ 55.69%

	FY22	Y/Y Change
Profit	$26.0M	↑ 12.01%

	FY23	Y/Y Change
Profit	$25.3M	↓ 2.69%

	FY24	Y/Y Change
Profit	$29.9M	↑ 17.91%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$3.9M	↓ 44.17%

	Q2 FY24	Q/Q Change
Profit	$7.4M	↑ 90.45%

	Q3 FY24	Q/Q Change
Profit	$8.3M	↑ 12.32%

	Q4 FY24	Q/Q Change
Profit	$9.1M	↑ 9.25%

	Q1 FY25	Q/Q Change
Profit	$5.5M	↓ 39.13%

	Q2 FY25	Q/Q Change
Profit	$6.4M	↑ 15.02%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-11.0M	↑ 23.67%
Investing Cash Flow	$-392.0K	↓ 66.41%
Financing Cash Flow	$22.2M	↑ 456.9%

	FY20	Y/Y Change
Operating Cash Flow	$4.1M	↓ 137.54%
Investing Cash Flow	$-9.0K	↓ 97.7%
Financing Cash Flow	$137.2M	↑ 516.95%

	FY21	Y/Y Change
Operating Cash Flow	$-29.1M	↓ 803.99%
Investing Cash Flow	$-737.0K	↑ 8088.89%
Financing Cash Flow	$94.7M	↓ 30.95%

	FY22	Y/Y Change
Operating Cash Flow	$-20.9M	↓ 28.03%
Investing Cash Flow	$-15.8M	↑ 2044.78%
Financing Cash Flow	$1.2M	↓ 98.76%

	FY23	Y/Y Change
Operating Cash Flow	$-25.1M	↑ 19.73%
Investing Cash Flow	$-26.4M	↑ 67.01%
Financing Cash Flow	$-15.9M	↓ 1451.57%

	FY24	Y/Y Change
Operating Cash Flow	$-30.2M	↑ 20.7%
Investing Cash Flow	$-46.3M	↑ 75.46%
Financing Cash Flow	$-376.0K	↓ 97.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-9.4M	↑ 384.82%
Investing Cash Flow	$-5.8M	↓ 224.68%
Financing Cash Flow	$-1.3M	↓ 1463.16%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-13.0M	↑ 39.36%
Investing Cash Flow	$-45.1M	↑ 680.47%
Financing Cash Flow	$367.0K	↓ 128.34%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-5.6M	↓ 57.0%
Investing Cash Flow	$3.8M	↓ 108.4%
Financing Cash Flow	$23.0K	↓ 93.73%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-2.2M	↓ 60.0%
Investing Cash Flow	$780.0K	↓ 79.42%
Financing Cash Flow	$529.0K	↑ 2200.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-15.0M	↑ 569.59%
Investing Cash Flow	$50.3M	↑ 6350.38%
Financing Cash Flow	$-189.0K	↓ 135.73%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-5.8M	↓ 61.49%
Investing Cash Flow	$-11.6M	↓ 123.03%
Financing Cash Flow	$-78.0K	↓ 58.73%

908 Devices Technicals Summary

Sell

Neutral

Buy

908 Devices is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

908 Devices Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
908 Devices Inc.	-4.66%	215.4%	67.88%	-65.87%	-87.26%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
908 Devices Inc.	NA	NA	NA	-0.39	-0.53	-0.15	NA	4.13
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
908 Devices Inc.	Buy	$225.9M	-87.26%	NA	-28.13%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Organization	908 Devices
Employees	246
CEO	Dr. Kevin J. Knopp Ph.D.
Industry	Technology

Key Management of 908 Devices Inc.

Name	Title
Dr. Kevin J. Knopp Ph.D.	Co-Founder, CEO, President & Director
Dr. Christopher David Brown Ph.D.	Co-Founder, Board Advisor & Director
Mr. Joseph H. Griffith IV	CFO & Treasurer
Mr. Michael S. Turner Esq., J.D.	Chief Legal & Administrative Officer and Secretary
Ms. Barbara Russo	VP of Marketing & Corporate Communications
Mr. Don Osmer	Vice President of Human Resources

Important FAQs about investing in MASS Stock from India :

What is 908 Devices share price today?

908 Devices share price today is $6.25 as on August 30, 2025 at 1:29 am IST at the close of the market. 908 Devices share today touched a day high of $6.27 and a low of $6.15.

What is the 52 week high and 52 week low for 908 Devices share?

908 Devices share touched a 52 week high of $8.06 and a 52 week low of $1.81. 908 Devices stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $6.25, lower by 22.46% versus the 52 week high.

How to invest in 908 Devices Stock (MASS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 908 Devices on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 908 Devices Shares that will get you 0.2400 shares as per 908 Devices share price of $6.25 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy 908 Devices Stock (MASS) from India?

Indian investors can start investing in 908 Devices (MASS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in 908 Devices stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on 908 Devices share’s latest price of $6.25 as on August 30, 2025 at 1:29 am IST, you will get 1.6000 shares of 908 Devices. Learn more about fractional shares .

What are the returns that 908 Devices has given to Indian investors in the last 5 years?

908 Devices stock has given -87.26% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?